Castro, R. OrtegaPilar, F. U.Martinez-Monllor, M.Munoz-Barrera, L.Sanchez-Pareja, I.Abalos-Aguilera, M. C.Puerto, N. BarbarrojaEstevez, E. CollantesAguirre-Zamorano, M. A.Perez-Sanchez, C.Lopez-Pedrera, C.2023-05-032023-05-032022-06-01Castro RO, Pilar FU, Martinez-Monllor M, Muñoz-Barrera L, Sanchez-Pareja I, Ábalos-Aguilera MC, et al. POS0488 IDENTIFICATION OF NOVEL DISEASE BIOMARKERS IN SYSTEMIC SCLEROSIS THROUGH HIGH-THROUGHPUT PROTEOMICS. Annals Of The Rheumatic Diseases [Internet]. 23 de mayo de 2022;81(Suppl 1):498.3-4990003-4967http://hdl.handle.net/10668/20122Background: Systemic sclerosis (SSc) is an autoimmune disease characterized by vasculopathy, tissue fibrosis and activation of the innate and adaptive immune system. Clinical features of the disease consist of skin thickening and internal organ involvement. Due to the heterogeneous nature of the disease, there is an unmet need of biomarkers for diagnosis, disease progression and response to treatment.enScleroderma, systemicFibrosisAutoimmune diseasesImmune systemBiomarkersDisease progressionconference outputopen accessBiomarcadoresProgresión de la enfermedadSistema inmunológico10.1136/annrheumdis-2022-eular.47381468-2060https://ard.bmj.com/content/annrheumdis/81/Suppl_1/498.3.full.pdf850279002022